Home » Stocks » OCDX

Ortho Clinical Diagnostics Holdings plc (OCDX)

Ortho Clinical Diagnostics will go public soon. The estimated IPO date is January 28, 2021.
Stock Price: $20.00 - $23.00
Current IPO price range
Market Cap 4.66B
Revenue (ttm) 1.72B
Net Income (ttm) -169.40M
Shares Out 216.58M
EPS (ttm) -0.78
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a
Trading Day n/a
Last Price n/a
Previous Close n/a
Change ($) n/a
Change (%) n/a
Day's Open n/a
Day's Range n/a
Day's Volume n/a
52-Week Range n/a

News

Hide News
PRNewswire - 3 days ago

Ortho Clinical Diagnostics Holdings plc ("Ortho"), the world's largest pure-play in vitro diagnostics company dedicated to improving and saving...

NASDAQ - 2 weeks ago

Ortho Clinical Diagnostics, a Carlyle-backed global provider of in vitro diagnostic products, filed on Monday with the SEC to raise up to $100 million in an initial public offering. However, t...

SEC - 2 weeks ago

Ortho Clinical Diagnostics Holdings plc has filed to go public with an IPO on the NASDAQ.

About OCDX

Ortho Clinical Diagnostics is a pure-play in vitro diagnostics (“IVD”) business driven by our credo, “Because Every Test is A Life.” This guiding principle reflects the crucial role diagnostics play in global health and guides our priorities as an organization. As a leader in IVD, we impact approximately 800,000 patients every day. We are dedicated to improving outcomes for these patients and saving lives through providing innovative and reliable diagnostic testing solutions to the clinical laboratory and transfusion medicine communitie... [Read more...]

Industry
Medical Devices
IPO Date
Jan 28, 2021
CEO
Chris Smith
Employees
4,500
Stock Exchange
NASDAQ
Ticker Symbol
OCDX
Full Company Profile

Financial Performance

In 2019, OCDX's revenue was $1.80 billion, an increase of 0.79% compared to the previous year's $1.79 billion. Losses were -$156.90 million, -36.94% less than in 2018.

Financial Statements